Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer
Palo Alto (17 mi)Age: Any Age
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: Alliance for Clinical Trials in Oncology
No Placebo Group
Trial Summary
What is the purpose of this trial?RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research study is looking at tissue samples in predicting oral cancer in patients who have undergone neck dissection for oral cancer.
Eligibility Criteria
Treatment Details
1Treatment groups
Experimental Treatment
Group I: Group 1Experimental Treatment3 Interventions
Patient tissue samples are screened using polymerase chain reaction (PCR) for human papilloma virus-specific primers. Samples are analyzed to identify a nodal-metastasis signature for oral squamous cell carcinoma. Samples also undergo microarray analysis to quantify expression levels for targeted genes. Initial data analysis is performed using Affymetrix® Microarray Suite 5.0 to quantify expression levels for targeted genes.
Find a clinic near you
Research locations nearbySelect from list below to view details:
Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA
Loading ...
Who is running the clinical trial?
Alliance for Clinical Trials in OncologyLead Sponsor
National Cancer Institute (NCI)Collaborator